Download presentation
Presentation is loading. Please wait.
Published byFlora Goodman Modified over 6 years ago
1
Copyright © 2004 American Medical Association. All rights reserved.
Elevation Acute Coronary SyndromesA Systematic Overview JAMA. 2004;292(1): doi: /jama Figure Legend: Test for heterogeneity: χ25 = 6.50, P = .02 (panel A); χ25 = 6.59, P = .25 (panel B). Black squares indicate odds ratios (ORs);horizontal lines, 95% confidence intervals (CIs). The size of each squarereflects the statistical weight of a trial in calculating the OR, and therelative sizes of the squares are accurate within each plot only. ESSENCEindicates Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave CoronaryEvents; TIMI 11B, Thrombolysis in Myocardial Infarction 11B; ACUTE II, AntithromboticCombination Using Torofiban and Enoxaparin II; INTERACT, Integrilin and EnoxaparinRandomized Assessment of Acute Coronary Syndrome Treatment; A to Z, Aggrastatto Zocor study; SYNERGY, Superior Yield of the New Strategy of Enoxaparin,Revascularization and Glycoprotein IIb/IIIa Inhibitors; UFH, unfractionatedheparin. Date of download: 10/26/2017 Copyright © 2004 American Medical Association. All rights reserved.
2
Copyright © 2004 American Medical Association. All rights reserved.
Elevation Acute Coronary SyndromesA Systematic Overview JAMA. 2004;292(1): doi: /jama Figure Legend: Test for heterogeneity: χ24 = 5.46, P = .24 (panel A); χ24 = 2.86, P = .58 (panel B). See Figure 1 legend for expansions oftrial names and discussion of sizes of squares. UFH indicates unfractionatedheparin. Date of download: 10/26/2017 Copyright © 2004 American Medical Association. All rights reserved.
3
Copyright © 2004 American Medical Association. All rights reserved.
Elevation Acute Coronary SyndromesA Systematic Overview JAMA. 2004;292(1): doi: /jama Figure Legend: Test for heterogeneity: χ23 = 1.39, P = .71 (panel A); χ23 = 5.63, P = .13 (panel B). See Figure 1 legend for expansions oftrial names and discussion of sizes of squares. UFH indicates unfractionatedheparin. Date of download: 10/26/2017 Copyright © 2004 American Medical Association. All rights reserved.
4
Copyright © 2004 American Medical Association. All rights reserved.
Elevation Acute Coronary SyndromesA Systematic Overview JAMA. 2004;292(1): doi: /jama Figure Legend: Test for heterogeneity: χ23 = 9.45, P = .02 (panel A); χ23 = 2.68, P = .44 (panel B). See Figure 1 legend for expansions ofnames of trials and discussion of sizes of squares. UFH indicates unfractionatedheparin. Date of download: 10/26/2017 Copyright © 2004 American Medical Association. All rights reserved.
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.